Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study

Summary

A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical product in Patients with Mild to Moderate Onychomycosis

Timeline

Start

2016-03-21

Primary completion

2018-03-06

Completion

2018-06-21

Outcome

Missed primary endpoint

registry analysis (superiority test); NVXT Topical Treatment Group B vs Placebo (Vehicle) Topical Treatment Group C; p = 0.4615; Z-test, 2 sided NCT02933879 ↗

Drugs

Indications